Please login to the form below

Not currently logged in
Email:
Password:

Wyeth shareholders approve merger

Wyeth investors have voted to approve Pfizer's proposed $68bn takeover by an overwhelming 98 per cent, according to a preliminary tally

Wyeth investors have voted to approve Pfizer's proposed $68bn takeover by an overwhelming 98 per cent, according to a preliminary tally.

The news follows the recent announcement that the European Commission has approved the deal, subject to Pfizer's pledge to shed certain animal-health assets in Europe. The deal is still subject to clearance by anti-trust regulators in the US.

New York-based Pfizer expects the deal to close by the end of the year. 

21st July 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics